News

FBC News20m
CID Director takes stand in former PM, COMPOL trial
Director of Criminal Investigations, Serupepeli Neiko took the stand this afternoon in the case involving former Prime ...
Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure
Ianalumab prolonged the duration of safe platelet levels during and after treatment in patients with primary immune thrombocytopenia (ITP) previously treated with corticosteroids1,2 Patients treated ...
Novartis Pharma AG: Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure
Ianalumab prolonged the duration of safe platelet levels during and after treatment in patients with primary immune thrombocytopenia (ITP) previously treated with corticosteroids1,2 Patients ...
FBC News55m
New dialysis machine boosts Labasa care
A $40,000 dialysis machine donated to Labasa Hospital’s Dialysis Centre is set to expand life-saving treatment for kidney ...